all 191371 studies found for:    ALL
Show Display Options
Rank Status Study
21 Completed Recurrence of Atrial Fibrillation in Patients With Dual-chamber Pacemakers and Drug Therapy
Condition: Atrial Fibrillation
22 Unknown  Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Interventions: Drug: carboplatin;   Drug: ifosfamide;   Procedure: hyperthermia treatment
23 Terminated
Has Results
Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer
Condition: Breast Cancer
Intervention: Drug: sorafenib
24 Recruiting Evaluation of 3 Different Doses of IV Busulfan
Conditions: Myelodysplastic Syndrome;   Acute Myeloid Leukemia
Interventions: Drug: BX2;   Drug: BX3;   Drug: BX4
25 Completed Primary UVB-311nm and Adalimumab in Psoriasis Patients
Condition: Psoriasis
Intervention: Radiation: UVB-311nm
26 Completed A Multidimensional Lifestyle Intervention to Reduce the Risk of Metabolic Disorders in Older Workers in Taiwan
Condition: Metabolic Disorder
Intervention: Behavioral: Multidimensional lifestyle intervention
27 Completed Magnetic Resonance Imaging Studies of Motor and Thought Processes
Conditions: Cerebrovascular Disorder;   Healthy;   Movement Disorder;   Nervous System Disease;   Spinal Cord Injury
28 Recruiting Be Healthy in Pregnancy (BHIP) With Nutrition and Exercise
Conditions: Pregnancy Complications;   Weight Gain
Intervention: Behavioral: Structured + monitored nutrition and exercise intervention
29 Active, not recruiting
Has Results
Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC
Condition: Neoplasms, Breast
Intervention: Drug: Lapatinib/nab-Paclitaxel
30 Recruiting Physical Activity Program in Children and Adolescents With Cancer : Assessment of Benefits on Physical, Psychological and Social Health.
Condition: Cancer
Intervention: Other: physical activities adapted to children
31 Completed
Has Results
Evaluate the Utility of 18FDG-PET as a Tool to Quantify Atherosclerotic Plaque (MK-0000-081 AM3)(COMPLETED)
Condition: Atherosclerotic Vascular Disease
Interventions: Drug: atorvastatin;   Drug: placebo
32 Completed Evaluation of Clinical Efficacy of Pentoxifylline on Patients With Glomerulonephritis
Condition: Primary Glomerulonephritis
Intervention: Drug: pentoxifylline
33 Recruiting VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors
Conditions: Adenocarcinoma;   Pancreatic Neoplasms
Interventions: Drug: X-82;   Drug: Everolimus;   Procedure: Blood draws for pharmacokinetic testing
34 Withheld [Trial of device that is not approved or cleared by the U.S. FDA]
35 Active, not recruiting A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
Conditions: Advanced Malignancies;   Carcinoma, Non-Small-Cell Lung;   Anaplastic Large Cell Lymphoma;   Diffuse Large Cell Lymphoma;   Inflammatory Myofibroblastic Tumors
Intervention: Drug: AP26113
36 Completed Risperidone Augmentation in Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Risperidone;   Drug: placebo
37 Completed Efficacy, Safety, and Tolerability of SAR231893 (REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Condition: Asthma
Interventions: Biological: SAR231893 (REGN668);   Drug: placebo;   Drug: Fluticasone/Salmeterol combination;   Drug: Fluticasone;   Drug: Albuterol
38 Active, not recruiting Safety and Efficacy of GS-9857 Plus Sofosbuvir/GS-5816 Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection
Condition: Hepatitis C Virus Infection
Interventions: Drug: GS-9857;   Drug: SOF/GS-5816
39 Completed Viscoat Versus Visthesia. A Comparative Study of Post-cataract Endothelial Cell Loss
Condition: Cataract
Interventions: Procedure: Viscoat;   Procedure: Visthesia
40 Completed Determine the Pharmacokinetics and Safety of Brivanib in Chinese Subjects With Advanced Primary Liver Cancer (Hepatocellular Carcinoma: HCC)
Condition: Hepatocellular Carcinoma
Intervention: Drug: Brivanib

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years